Advice on heart transplants.
نویسندگان
چکیده
منابع مشابه
ABO-incompatible heart transplants.
A month-old baby girl with blood type O positive received a donor heart organ from a donor with blood type B. This was the first institutional ABO-incompatible heart transplant. Infants listed for transplantation may be considered for an ABO-incompatible heart transplant based on their antibody levels and age. The United Network of Organ Sharing (UNOS) protocol is infants under 24 months with t...
متن کاملMinimizing infection risks after paediatric organ transplants: Advice for practitioners.
Paediatric patients who have undergone an organ transplant face risks associated with different infectious diseases. Their susceptibility is increased by treatment with immunosuppressive medications. More of these patients are being cared for in community settings. This practice point provides guidance on key aspects in the prevention and treatment common infections.
متن کاملABO mismatching errors in heart transplants.
3 Roff SR. Underascertainment of multiple myeloma challenges robustness of third NRPB study of nuclear veterans. Published online March 7, 2003. http://bmj.com/cgi/eletters/326/7387/468/d# 30234 (accessed June 30, 2003). 4 Johnson JC, Thaul S, Page WF, Crawford H. Mortality of Veteran Participants in the CROSSROADS Nuclear Test. Washington, DC: National Academy Press, 1996. 5 Darby SC, Kendall ...
متن کاملHeart transplants for patients with Chagas' heart disease.
The role of heart transplants for treating Chagas' heart disease is not quite clear. Immunosuppression could lead to resurgence of T. cruzi infection with acute or chronic damage to the allograft. There are few publications regarding this issue. Thus we reported the follow-up of 18-patients with Chagas' heart disease submitted to orthotopic heart transplants from 1985 to 1993 at The Heart Insti...
متن کاملInvasive pulmonary Aspergillosis in organ transplants--Focus on lung transplants.
Infections with filamentous fungi are common in transplant recipients. The risk for aspergillosis and other invasive pulmonary mycosis (IPM) is high in patients undergoing stem cell and lung transplantations. The mortality rates range from 20% to 60% and depend on a number of risk factors. The typical manifestations of IPM are lung infiltrates, consolidations, and fungal tracheobronchitis. The ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1973
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.2.5862.363